DSpace Repository

Browsing Enfermedades Desmielinizantes.artículos by Author "Montalban, Xavier"

Browsing Enfermedades Desmielinizantes.artículos by Author "Montalban, Xavier"

Sort by: Order: Results:

  • A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study 
    Giovannoni, Gavin; Boyko, Alexey; Correale, Jorge; Edan, Gilles; Freedman, Mark S.; Montalban, Xavier; Rammohan, Kottil; Stefoski, Dusan; Yamout, Bassem; Leist, Thomas; Aydemir, Aida; Borsi, Laszlo; Verdun di Cantogno, Elisabetta (Future Medicine, 2023-08-03)
    What is this summary about?: Previous studies have shown that people living with multiple sclerosis (MS) treated with cladribine tablets have fewer relapses (where new symptoms occur or existing symptoms get worse for 24 ...
  • Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study 
    Giovannoni, Gavin; Boyko, Alexey; Correale, Jorge; Edan, Gilles; Freedman, Mark S.; Montalban, Xavier; Rammohan, Kottil; Stefoski, Dusan; Yamout, Bassem; Leist, Thomas; Aydemir, Aida; Borsi, Laszlo; Verdun di Cantogno, Elisabetta (Sage, 2023-04-03)
    Background: CLASSIC-MS evaluated the long-term efficacy of cladribine tablets in patients with relapsing multiple sclerosis. Objective: Report long-term mobility and disability beyond treatment courses received in ...
  • Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis 
    Zuluaga, María I.; Otero-Romero, Susana; Rovira, Álex; Perez Hoyos, Santiago; Arrambide, Georgina; Negrotto, Laura; Galán, Ingrid; Río, Jordi; Comabella, Manuel; Nos, Carlos; Arévalo, María Jesus; Vidal Jordana, Angela; Castilló, Joaquín; Rodríguez, Breogán; Midaglia, Luciana; Mulero, Patricia; Mitjana, Raquel; Auger, Cristina; Sastre Garriga, Jaume; Montalban, Xavier; Tintoré, Mar (Lippincott Williams & Wilkins, 2019-03-01)
    Objective: To investigate the effect of menarche, pregnancies, and breastfeeding on the risk of developing multiple sclerosis (MS) and disability accrual using a multivariate approach based on a large prospective cohort ...
  • Multiple sclerosis progression: time for a new mechanism-driven framework 
    Kuhlmann, Tanja; Moccia, Marcello; Coetzee, Timothy; Cohen, Jeffrey A.; Graves, Jennifer; Marrie, Ruth Ann; Montalban, Xavier; Yong, V. Wee; Thompson, Alan J.; Reich, Daniel S.; Correale, Jorge; International Advisory Committee on Clinical Trials in Multiple Sclerosis (Lancet Pub. Group, 2022-11-18)
    Traditionally, multiple sclerosis has been categorised by distinct clinical descriptors-relapsing-remitting, secondary progressive, and primary progressive-for patient care, research, and regulatory approval of medications. ...
  • Ofatumumab versus Teriflunomide in Multiple Sclerosis 
    Hauser, Stephen L.; Bar-Or, Amit; Comi, Giancarlo; Correale, Jorge; Coyle, Patricia K.; Cross, Anne H.; de Seze, Jerome; Leppert, David; Montalban, Xavier; Selmaj, Krzysztof; Wiendl, Heinz; Kerloeguen, Cecile; Willi, Roman; Li, Bingbing; Kakarieka, Algirdas; Tomic, Davorka; Goodyear, Alexandra; Pingili, Ratnakar; ASCLEPIOS I and ASCLEPIOS II Trial Groups (Massachusetts Medical Society, 2020-08-06)
    Background: Ofatumumab, a subcutaneous anti-CD20 monoclonal antibody, selectively depletes B cells. Teriflunomide, an oral inhibitor of pyrimidine synthesis, reduces T-cell and B-cell activation. The relative effects of ...

Search DSpace


Browse

My Account